BLLNNasdaqServices-Medical LaboratoriesFiscal year ends December 31

BillionToOne, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026

$101.03+2.91 (+2.97%)

Close on Oct 19, 2026

Market cap: $5.50B
P/E (TTM): 721.6
Dividend yield: –

BillionToOne, Inc. cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31
Depreciation & Amortization	6.90	7.00	5.90
Stock-Based Compensation	16	8.36	4.85
Deferred Income Taxes	0	0	0
Change in Accounts Receivable	-17	-16	-2.59
Change in Inventory	-8.81	-1.54	-1.41
Change in Accounts Payable	1.78	0.88	0.15
Change in Unearned Revenue	0.67	-0.22	3.02
Operating Cash Flow	25	-41	-54
Capital Expenditures	-8.88	-5.40	-6.17
Investing Cash Flow	-8.92	-5.43	83
Share Repurchases	0	-0.55	0
Debt Issued	0	50	15
Debt Repaid	0	-35	0
Financing Cash Flow	289	141	13
Net Change in Cash	304	94	43
Free Cash Flow	16	-47	-60
Income Taxes Paid	0.49	0.01	0
Interest Paid	4.65	3.92	2.58

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 71.3%
Operating margin: 10.9%
Net margin: 9.5%
Return on equity, FY2025: 6.5%

Financial strength

Current ratio: 11.69
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 984.5%

Valuation

P/E ratio: 721.6
Price to sales: 13.84
Price to book: 10.25
Dividend yield: –